Compounds > suramin

Page last updated: 2024-08-16

suramin and amphotericin b

suramin has been researched along with amphotericin b in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (27.27)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (18.18)	29.6817
2010's	6 (54.55)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Salem, MM; Werbovetz, KA	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Anklin, C; Bahar, M; Deng, Y; Doskotch, RW; Drew, ME; Gil, RR; He, S; Kinghorn, AD; Navarro-Vázquez, A; Pandharkar, T; Werbovetz, KA; Zhu, X	1
Agarwal, H; Bahar, M; Brun, R; Cason, E; Doskotch, RW; Drew, ME; Endeshaw, M; He, S; Kaiser, M; Kinghorn, AD; Li, C; Mahasenan, KV; Munde, M; Pandharkar, T; Werbovetz, KA; Wilson, WD; Zhu, X	1
Bero, J; Frédérich, M; Leverrier, A; Palermo, J; Quetin-Leclercq, J	1
Amata, E; Devine, W; Erath, J; Lee, PJ; Leed, SE; Mensa-Wilmot, K; Patel, G; Pollastri, MP; Rodriguez, A; Roncal, NE; Sciotti, RJ; Swaminathan, U; Woodring, JL	1
Kammerer, WS; Perez-Esandi, MV	1
Clarkson, AB; Rosenberg, C; Williams, DE	1
Rada, B	1
Evans, RJ; Lewis, CJ	1

Reviews

1 review(s) available for suramin and amphotericin b

Article	Year
[Experimental chemotherapy of AIDS]. Casopis lekaru ceskych, 1988, May-27, Volume: 127, Issue:22 Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antimony; Antiviral Agents; Humans; Oligopeptides; Peptide T; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine	1988

Other Studies

10 other study(ies) available for suramin and amphotericin b

Article	Year
Antiprotozoal compounds from Psorothamnus polydenius. Journal of natural products, 2005, Volume: 68, Issue:1 Topics: Animals; Antiprotozoal Agents; Chlorocebus aethiops; Fabaceae; Inhibitory Concentration 50; Leishmania donovani; Macrophages; Plants, Medicinal; Trypanosoma brucei brucei; Vero Cells	2005
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Potent antiprotozoal activity of a novel semi-synthetic berberine derivative. Bioorganic & medicinal chemistry letters, 2011, May-01, Volume: 21, Issue:9 Topics: Animals; Antiprotozoal Agents; Berberine; Chlorocebus aethiops; Disease Models, Animal; Inhibitory Concentration 50; Leishmania; Leishmaniasis; Malaria; Mice; Models, Molecular; Parasites; Plasmodium falciparum; Protozoan Infections; Trypanosoma brucei brucei; Trypanosomiasis; Vero Cells	2011
8,8-dialkyldihydroberberines with potent antiprotozoal activity. Journal of natural products, 2013, Mar-22, Volume: 76, Issue:3 Topics: Animals; Antimalarials; Antiprotozoal Agents; Berberine Alkaloids; Crystallography, X-Ray; Female; Inhibitory Concentration 50; Leishmania donovani; Mice; Mice, Inbred BALB C; Parasitic Sensitivity Tests; Plasmodium falciparum; Trypanosoma	2013
Antiparasitic hybrids of Cinchona alkaloids and bile acids. European journal of medicinal chemistry, 2013, Volume: 66 Topics: Antiparasitic Agents; Bile Acids and Salts; Cell Line; Cinchona Alkaloids; Humans; Inhibitory Concentration 50	2013
Protozoan Parasite Growth Inhibitors Discovered by Cross-Screening Yield Potent Scaffolds for Lead Discovery. Journal of medicinal chemistry, 2015, Jul-23, Volume: 58, Issue:14 Topics: Animals; Antiprotozoal Agents; Drug Discovery; Drug Evaluation, Preclinical; Growth Inhibitors; Hep G2 Cells; Humans; Parasites; Quinazolines	2015
Chemotherapy of experimental Echinococcus granulosus infection. Trials in CF1 mice and jirds (Meriones unguiculatus). The American journal of tropical medicine and hygiene, 1975, Volume: 24, Issue:1 Topics: Administration, Oral; Alkanesulfonates; Amidines; Amphotericin B; Animals; Echinococcosis; Echinococcus; Female; Fumarates; Gerbillinae; Humans; Injections, Intramuscular; Injections, Intraperitoneal; Iodized Oil; Methotrexate; Methyl Ethers; Mice; Phenyl Ethers; Rifampin; Suramin; Thymol	1975
Efficacy of DL-alpha-difluoromethylornithine in a rat model of Pneumocystis carinii pneumonia. Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:8 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Dapsone; Diminazene; Disease Models, Animal; Drug Combinations; Eflornithine; Female; Immunosuppression Therapy; Pneumonia, Pneumocystis; Random Allocation; Rats; Rats, Inbred Strains; Sulfamethoxazole; Suramin; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination	1988
Lack of run-down of smooth muscle P2X receptor currents recorded with the amphotericin permeabilized patch technique, physiological and pharmacological characterization of the properties of mesenteric artery P2X receptor ion channels. British journal of pharmacology, 2000, Volume: 131, Issue:8 Topics: Adenosine Triphosphate; Amphotericin B; Animals; Calcium; Cell Membrane Permeability; Dose-Response Relationship, Drug; Guanosine Triphosphate; Immunohistochemistry; Ion Channels; Male; Membrane Potentials; Mesenteric Arteries; Muscle, Smooth, Vascular; Patch-Clamp Techniques; Pyridoxal Phosphate; Rats; Rats, Wistar; Receptors, Purinergic P2; Receptors, Purinergic P2X; Receptors, Purinergic P2X2; Receptors, Purinergic P2X3; Receptors, Purinergic P2X4; Receptors, Purinergic P2X5; Receptors, Purinergic P2X7; Suramin; Thionucleotides; Time Factors	2000